drugset / Trial / NCT04345406

Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19

NCT04345406

Phase 3 Not yet recruiting 60 enrolled Tanta University
RandomizedParallel-groupOpen-labelTreatment

Summary

ACEIs as treatment for COVID19

Timeline

Start
2020-04-15
Primary completion
2029-12-01
Completion
2029-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Captopril Small molecule
Subject Enalapril Other / unclassified
Background alexoquine Unknown

Indications